Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OssiMend Bioactive Moldable in Posterolateral Instrumented Lumbar Fusion

NCT04775537 is registered in ClinicalTrials.gov with Collagen Matrix as lead sponsor.

NCT NCT04775537
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04775537 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OssiMend Bioactive Moldable in Posterolateral Instrumented Lumbar Fusion
Lead sponsor
Collagen Matrix
Phase
Observational
Overall status
Recruiting
Start date
January 21, 2021
Completion date
January 30, 2027
Enrollment
120 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

degenerative disc disease, spinal disease